Study details a link between inflammation and cancer
Timing of inflammation determines whether potentially cancerous mutations may arise.
Of yeast, ecology, and cancer
Jeff Gore’s work with baker’s yeast helps ecologists respond to trends, like vanishing fisheries and collapsing honeybee colonies.
In a body that rebels, the search for a delicate balance
Rhodes Scholar Elliot Akama-Garren seeks to harness the power of the immune system to combat cancer.
Proteins drive cancer cells to change states
When RNA-binding proteins are turned on, cancer cells get locked in a proliferative state.
Two sensors in one
Nanoparticles that enable both MRI and fluorescent imaging could monitor cancer, other diseases.
Sangeeta Bhatia named one of Foreign Policy's 100 Leading Global Thinkers
Bhatia recognized for work developing low-cost, noninvasive diagnostics for colon cancer.
Herman Eisen, professor emeritus of biology, dies at 96
Eisen was a pioneering immunologist and longstanding member of MIT’s cancer research community.
Better chemotherapy through targeted delivery
New approach could kill tumor cells in the brain more effectively and avoid side effects.
Fast modeling of cancer mutations
New genome-editing technique enables rapid analysis of genes mutated in tumors.
Big step in battling bladder disease
Novel device that stays in the bladder and slowly releases drugs sells to pharmaceutical giant.
Martial arts and medical outreach
Senior Christina Lalani applies lessons she learned from karate to global health disparities.
Biologists find an early sign of cancer
Patients show boost in certain amino acids years before diagnosis of pancreatic cancer.
Researchers engineer new mouse model to study disease
Time-saving tool takes advantage of CRISPR gene-editing technology.
Chemists recruit anthrax to deliver cancer drugs
With some tinkering, a deadly protein becomes an efficient carrier for antibody drugs.